In support of ADHD awareness month this October, the Health Innvovation Network is highlighting the impact of the innovation QbTest – an objective assessment tool to assist in the diagnosis of ADHD. Three quarters of all NHS trusts that provide ADHD services have adopted the innovation and since April 2020, more than 77,000 children and young people have benefited, around 95,000 hours of clinical capacity have been released and an estimated £38.5M of cost savings have been achieved for the NHS.
The National Institute for Health and Care Excellence (NICE) estimates the global prevalence of ADHD in children to be around 5% (1 in 20). Undiagnosed and/or untreated ADHD can have a significant impact on personal development, academic outcomes and family interaction. Additional mental health problems related to poor management of ADHD can include depression, anxiety, sleep and eating disorders.
Following a successful randomised control trial by the NIHR East Midlands CLAHRC (now the East Midlands ARC), Health Innovation East Midlands (HIEM) piloted the use of QbTest within three NHS mental health trusts – this CLAHRC and HIEM collaboration provided the evidence base for a national programme called Focus ADHD, which was rolled out across England between 2020 and 2023 by the Network.
The innovative tool measures the three core indicators of ADHD – attention, impulsivity and motor activity – and when used to supplement clinical assessment can significantly reduce the time to diagnosis, freeing up clinical time and saving money.
In July 2024, NICE recommended the use of the QbTest to help diagnose ADHD in children and young people.
Nicole McGlennon, Health Innovation East Midlands Managing Director said: “The legacy of this programme speaks for itself. I’m proud that we have supported this innovation and that it is helping so many children and young people receive an accurate and objective diagnosis for ADHD.
“What is so pivotal is although the formal national programme has ended, the impacts continue to be sustained and continue to accelerate. We can see the evidence that since hospital trusts have adopted it has become ‘business as usual’ and has transformed how they deliver care for ADHD. Since our formal involvement ended a further 10 trusts adopted QbTest during 2024 benefiting over 15,000 more children and young people.”
Tony Doyle, Managing Director, Qbtech added: “Health Innovation Networks (HINs) have helped to open doors and understand what’s going on locally in ADHD services and have helped to broker introductions. We have received outstanding support from the Health Innovation Network. The support of HINs across England has helped us with the expansion of the innovation QbTest. Together we have made a real difference and continue to improve the lives of those living with ADHD.”
In October 2023, the national network published “A Guide to Innovation, Implementation, Readiness, and Resourcing“, offering practical insights for healthcare organisations aiming to integrate cutting-edge technologies like the QbTest. This guide serves as a valuable resource for spreading and sustaining healthcare innovations across the NHS.
Dr Cheryl Crocker, interim Chief Operating Officer at the Health Innovation Network, explains the vital role innovation plays to not only reduce waiting lists and improve access to care, but to decrease system pressure by improving people’s health and keeping them well for longer. The new Government has rightly declared its focus on moving the [...]
Launched in 2014, SiSU Health is scaling early warning, self-service health kiosks, digital platforms and pathways into pre-existing healthcare services. The British Heart Foundation estimates the annual cardiovascular disease (CVD) related costs to the UK healthcare system are around £10 billion, with annual costs to the UK economy of an estimated £25 billion. Making the [...]
BEAT HF is the first UK-wide disease awareness campaign for heart failure and is targeted at the public and primary care healthcare professionals. Professor Clare Taylor, Nick Hartshorne-Evans, and Dr Dargoi Satchi developed BEAT to improve awareness of heart failure through early recognition of common symptoms. The acronym BEAT leads to testing using a commonly [...]
